🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Investigational Treatment Gaining Traction Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are urged to contact these accounts privately for source information, while also receiving promotional offers.

Thriving Commerce on Social Networks

Additionally, a robust market exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and assertions of next-day UK delivery. Vendors market the substance there before redirecting customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Professionals Express Worries

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unapproved medication in the UK is a cause for concern and could result in individuals injecting substances of uncertain source.

Several professionals said the demand for the experimental drug could be connected to the increasing price of licensed slimming products such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the British medical regulations.

Several influencers try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to fines, legal action or imprisonment.

Platform Response and Material Removal

Based on the social media company, the platform has taken down violative material and banned associated hashtags and search suggestions. The company stated it was committed to maintaining the service secure and investing in strengthening enforcement strategies.

Online Marketplace Activities

Research also discovered groups with up to 9,000 participants selling retatrutide using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately brings up channels with thousands of users, populated with images of weight loss, glowing testimonials and step-by-step guides for preparing or administering at home.

After moments of joining one community, a seller shared contact information, where most transactions take place. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about weight, medical conditions or previous experience.

Item Information and Pricing

Inside these communities, messages show black plastic parcels with Royal Mail labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A representative for the messaging service stated it regularly monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they can’t verify. Although the science behind retatrutide is sound, these online products may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.

Her staff has already encountered individuals injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet authorized … may subject patients to potentially serious medical dangers”.